MicroPort NeuroTech Limited
MicroPort NeuroTech Limited engages in the research and development, production, and sale of neuro-interventional medical devices in the People's Republic of China and internationally. It offers NUMEN, a coil embolization system; NUMEN FR, a coil detachm…
Medical - Devices
CN, Shanghai [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | 100.00 | 36.05 | 0.00 | |
| Graham Fair Price | 100.00 | 3.09 | 0.00 | |
| PEG | 0.00 | 0.00 | 0.00 | |
| Price/Book | 100.00 | 3.82 | 0.00 | |
| Price/Cash Flow | 100.00 | 62.08 | 0.00 | |
| Prices/Earnings | 100.00 | 17.75 | 0.00 | |
| Price/Sales | 100.00 | 15.79 | 0.00 | |
| Price/FCF | 100.00 | 62.08 | 0.00 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 100.00 | 0.76 | 0.00 | |
| Operating Margin | 100.00 | 0.32 | 0.00 | |
| ROA | n.A. | 0.04 | n.A. | |
| ROE | n.A. | 0.05 | n.A. | |
| ROIC | n.A. | 0.06 | n.A. | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | 0.63 | -0.49 | 30.24 | |
| Dividends QOQ | 0.00 | 0.00 | 0.00 | |
| EBIT QOQ | 0.00 | 0.00 | 0.00 | |
| EPS QOQ | 0.00 | 0.00 | 0.00 | |
| FCF QOQ | 0.00 | 0.00 | 0.00 | |
| Revenue QOQ | 0.00 | 0.00 | 0.00 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Bad
Fundamentals
Leverage & Liquidity
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 0.00 | 191.82 | 100.00 | |
| Days Sales Outstanding (DSO) | 0.00 | 2.40 | 100.00 | |
| Inventory Turnover | n.A. | 0.47 | n.A. | |
| Debt/Capitalization | 0.02 | 0.04 | 61.02 | |
| Quick Ratio | 3.31 | 4.07 | 23.09 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| Book Value | 0.00 | 2.81 | 100.00 | |
| Cash | 0.00 | 1.72 | 100.00 | |
| Capex | 0.00 | -0.05 | -100.00 | |
| Free Cash Flow | 0.00 | 0.17 | 100.00 | |
| Revenue | 0.00 | 0.68 | 100.00 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Best
Fundamentals
Financial Health
06 - Financial Health ·
Bad